Dermira (DERM) Will Make Late-Breaking Presentation of DRM04 Phase 3 Data at EADV Congress
Tweet Send to a Friend
Dermira, Inc. (Nasdaq: DERM) announced that data from its DRM04 Phase 3 clinical program in patients with primary axillary hyperhidrosis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
